Market Analysis and Insights:- Global PCR Multiplex Assays Market
Global PCR Multiplex Assays Market By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026
Multiplex assays are the new technology which is incorporated with the capability to run more than one target sequence in a single step, the evolution of the PCR multiplex assays in terms of smart features with voice command, facial authentication and radio-frequency identification (RFID) features changes from an manual instrument to an automated PCR multiplexes systems in the year 2016 to 2018.
Multiplex assay can amplify more than one target sequence with the help of multiple primer pairs in reaction mixtures. The PCR technique is a time saving with significant less efforts in the laboratory experiments, which is a convenient and rapid screening assay for clinical and research laboratories. The PCR multiplex assay manufactures to expand their business SWOT Analysis and Forecastfor the development of services. For instance In June 2018, QIAGEN announced the launch of QIAseq 16S Panels and UCP Multiplex PCR kit which enables in the profiling of complex microbiome samples. The new products reduce the profiling bias and a kit is featured with the nucleic acid-depleted reagents which are tested for the fungal and bacterial DNA contamination. QIAseq 16S Panels enhances robust profiling with the flexibility and interrogates of fungal ITS regions and bacterial 16S variable regions on Illumina platforms. The product is designed with unbiased microbiome profiling and helping scientists to avoid external biased obstacle. The introduction of product helps clinicians in microbial profiling and expanded the advanced product portfolio of the company.
Global PCR multiplex assays market is projected to register a CAGR of 7.2% in the forecast period of 2019 to 2026.
Get More Insights About the Global PCR Multiplex Assays Market, Request Sample@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...
Segmentation: Global PCR Multiplex Assays Market
Global PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.
• On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.
o In June 2017, Bio-Rad Laboratories, Inc. launched a RT-PCR kit which allows researchers to screen samples for dengue (DENV1, DENV2, DENV3, DENV4), Zika (ZIKV) and chikungunya (CHIKV) arbovirus RNAs. The assays comprise the controls which researchers needs for the validation of results. The launch of the products helps researchers to rely on wet-lab validated tool and helps manufacturers in GMP-approved facilities to obtain consistent results.
• On the basis of application, the market is segmented into research & development and clinical diagnostics.
Know more about this https://www.databridgemarketresearch.com/reports/global-pcr-multipl...
o In November 2018, Biomérieux SA, Inc. announced the acquisition of Suzhou Hybiome Biomedical Engineering Co. Ltd. (China). The company specializes in immunoassay testing in a more innovative manner providing high throughput result. This acquisition gives Biomérieux SA an opportunity to widen their portfolio making it even stronger.
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.
o In March 2019, Biomérieux SA, Inc. announced an agreement with International Symposium on Intensive Care and Emergency Medicine (ISICEM) for the development of future biomarkers for rapidly identifying treatment of acute kidney injury (AKI).
Competitive Analysis: Global PCR Multiplex Assays Market
Some of the major players operating in this market are HOL0GIC INC, LUMINEX CORPORATION., BECTON, DICKINSON AND COMPANY, ABBOTT, Thermo Fisher Scientific Inc, QIAGEN, Agilent Technologies Inc, Meso Scale Diagnostics, LLC, Randox Laboratories Ltd., Bio-Techne, Seegene Inc., Olink, Illumina, Inc, Bio-Rad Laboratories, Inc, Abcam Plc, Quanterix, Sysmex Corporation, Siemens, Diasorin, Quest Diagnostics Incorporated, PerkinElmer Inc, Eurofins Scientific, Agena Bioscience, Inc, F. Hoffmann-La Roche Ltd, among others.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-pcr-multi...
Recent Developments:
• In April 2019, Thermo Fisher Scientific Inc. announced the launch of Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR systems; It has capabilities like facial authentication, voice commands, radio-frequency identification (RFID)-enabled plate scanning, and quick access to service and support with a single touch. After the launch of the product this company has enhanced their portfolio showcase in the market.
• In September 2018, Sysmex Inostics subsidiary of Sysmex Corporation (Japan), announced the launch of oncobeam EGFR kit v2 for research only in Europe and Asia. The kit is used to perform for highly sensitive cDNA analysis of colon and non-small cell lung cancer samples. This kit has feature of workflow improvement, which include internal quantifier to eliminate up-front DNA quantification steps, and which decreases the amount of hands-on sample processing. It is a flexible kit which can run 3 to 10 sample in a single process.
• In January 2018, Siemens Healthineers announced the closing of the acquisition of Fast Track Diagnostics (Luxembourg) which expanded Siemens molecular diagnostics portfolio. The acquisition will bring the low cost, integrated and high quality products of Fast Track Diagnostics in the molecular solution of Siemens Healthineers.
Access Full report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/gl...
Research Methodology: Global PCR Multiplex Assays Market
Primary Respondents:
Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.
Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

BROWSE RELATED REPORTS
• Asia-Pacific PCR Multiplex Assays Market – Industry Trends - Forecast to 2026
• Europe PCR Multiplex Assays Market – Industry Trends - Forecast to 2026
• Middle East and Africa PCR Multiplex Assays Market – Industry Trends - Forecast to 2026

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]